Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advanced Molecular Imaging of Cholestatic Disorders in Humans: Pathophysiological Characterization and Treatment Effects

NCT06604923 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT06604923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06604923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advanced Molecular Imaging of Cholestatic Disorders in Humans: Pathophysiological Characterization and Treatment Effects
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Active, not recruiting
Start date
September 4, 2024
Completion date
June 30, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bezafibrate, cholestasis, cirrhosis, primary biliary cholangitis (pbc), ursodeoxycholic acid